We’re entering a new era of medicine – one where aging itself is treated as a problem to solve.
In this Prof G+ Deep Dive, Scott breaks down the rise of the longevity economy, from GLP-1 drugs to peptides, and explains why the science is advancing faster than access.
The result: a system where the people most able to extend their healthspan are often the ones who need it least.
Because in the future of health, living longer may depend less on biology and more on income.
If you’re not a Prof G+ subscriber yet and want access to these weekly deep dives, make sure to subscribe below for all of Prof G Media’s exclusive content, plus livestreams and ad-free pods.
